Impact of comorbidity on survival in peripheral T-cell lymphomas: A Swedish Lymphoma Registry study. (Q38802896)

From Wikidata

Jump to navigation Jump to search

scientific article published on 5 May 2017

Impact of comorbidity on survival in peripheral T-cell lymphomas: A Swedish Lymphoma Registry study

Language	Label	Description	Also known as
English	Impact of comorbidity on survival in peripheral T-cell lymphomas: A Swedish Lymphoma Registry study.	scientific article published on 5 May 2017	Impact of comorbidity on survival in peripheral T-cell lymphomas: A Swedish Lymphoma Registry study

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28474339%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Impact of comorbidity on survival in peripheral T-cell lymphomas: A Swedish Lymphoma Registry study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28474339%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

based on heuristic

inferred from title

author name string

Jenny Törnqvist

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28474339%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Lars Brudin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28474339%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Thomas Relander

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28474339%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

5 May 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28474339%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Hematological Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28474339%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28474339%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28474339%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

159-165

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28474339%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

Differential prognostic impact of comorbidity

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

Prognostic importance of comorbidity in a hospital-based cancer registry

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

Comparison of outcomes among patients aged 80 and over and younger patients with diffuse large B-cell lymphoma: a population based study.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

Prognostic value of comorbidity for auto-SCT eligibility and outcome in relapsed or refractory aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

21 January 2018

A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

7 January 2021

based on heuristic

inferred from DOI database lookup

Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

7 January 2021

based on heuristic

inferred from DOI database lookup

Charlson Comorbidity Index is an independent prognostic factor among elderly patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2428

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HON.2428

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28474339%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

release_n2whs5v7lbfm5astsapc5g2swy

1 reference

https://api.fatcat.wiki/v0/release/n2whs5v7lbfm5astsapc5g2swy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28474339%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38802896&oldid=1840168376"